Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Lobbyists: DERRICK M WHITE; CYNTHIA BROWN; ELIZABETH GREER; KRISTINA DUNKLIN; mr MICHAEL ALEXANDER WILLIAMS
Government entities lobbied:HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Lobbyists: DERRICK M WHITE; CYNTHIA BROWN; ELIZABETH GREER; KRISTINA DUNKLIN; mr MICHAEL ALEXANDER WILLIAMS
Government entities lobbied:HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/Appropriations
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).
Lobbyists: DERRICK M WHITE; CYNTHIA BROWN; ELIZABETH GREER; KRISTINA DUNKLIN; mr MICHAEL ALEXANDER WILLIAMS
Government entities lobbied:HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.
Estimated value: $180/mo per user — but we made it free.